LIMN logo

LIMINATUS PHARMA INC-CL A

LIMNNASDAQ
๐Ÿ† #4175 by market capUS Equity
$0.11โ–ผ $0.01 (โˆ’4.70%)
๐ŸŒ… Pre-market$0.11โ–ฒ 0.00%Regular close ยท extended-hours price shown
1hโ€”
24hโ–ผ 4.7%
7dโ–ฒ 5.4%
14dโ–ฒ 7.0%
30dโ–ฒ 3.1%
1yโ–ผ 97.4%
๐ŸฆMarket Cap
$7M
Small Cap
๐Ÿ“ˆRevenue Growth (YoY)
โ€”
๐Ÿ“ŠGross Margin
โ€”
๐Ÿ’ตFCF Margin
โ€”
โš–๏ธP/S Ratio
โ€”
Otter Score
55
Weak

Trading Snapshot

Day Range
$0.11 โ€“ $0.11
52-Week Range
$0.10 โ€“ $4.85
Volume
$3.02B
Avg Volume
$3.01B
Shares Outstanding
67.2M
Next Earnings
Sep 25, 2026

Fundamentals Snapshot

Annual Revenue
$470,965
Last Q Revenue
$113,600
P/E Ratio
โ€”
P/S Ratio
โ€”
EPS (TTM)
$-0.58
Dividend Yield
โ€”

Why Investors Own LIMN

  • โœ“High-growth profile โ€” revenue up -3.2% YoY with expanding US Equity exposure.
  • โœ“Healthy economics โ€” 27% gross margin and 21% free-cash-flow margin.
  • โœ“New products and segments could unlock additional revenue streams.
โš ๏ธ Key Risks

Execution delays, intensifying competition, and valuation compression if growth decelerates.

Financial Trends

Revenue (TTM)
$470,965โ–ผ โˆ’2.0% YoY
Gross Margin (TTM)
26.7%โ–ฒ +0.3% YoY
Operating Income (TTM)
$106,909โ–ผ โˆ’2.0% YoY
Free Cash Flow (TTM)
$100,786โ–ผ โˆ’2.0% YoY

About LIMINATUS PHARMA INC-CL A

Liminatus Pharma, Inc. is an immuno-oncology firm, currently in its clinical development phase, dedicated to pioneering new treatments for cancer. The company's headquarters are located in La Palma, California.

๐Ÿฆฆ

Otter Score Breakdown

โ“˜
๐Ÿ’ŽQualityโ˜…โ˜…โ˜…โ˜…โ˜…
๐Ÿš€Growthโ˜…โ˜…โ˜…โ˜…โ˜…
โš–๏ธValuationโ˜…โ˜…โ˜…โ˜…โ˜…
โšกMomentumโ˜…โ˜…โ˜…โ˜…โ˜…
Overall Score
Weak
55/100

Analyst Price Target

โ“˜
Average Target
$0.14
โ–ฒ +29.0% Upside
High Target$0.16
Low Target$0.11
Based on 23 analysts

Latest News & Updates

Benzingaยท25d ago

12 Health Care Stocks Moving In Friday's Intraday Session

Gainers Jasper Therapeutics (NASDAQ:JSPR) stock moved upwards by 19.2% to $0.92 during Friday's regular session. The company's market cap stands at $21.6 million. Kalaris Therapeutics (NASDAQ:KLRS) shares

ChartMillยท25d ago

What's going on in today's pre-market session

Before the US market kicks off on Friday, let's examine the pre-market session and unveil the notable performers among the top gainers and losers.

Benzingaยท25d ago

12 Health Care Stocks Moving In Friday's Pre-Market Session

Gainers Anixa Biosciences (NASDAQ:ANIX) shares rose 10.0% to $3.65 during Friday's pre-market session. The market value of their outstanding shares is at $112.9 million. Barinthus Biotherapeutics (NASDAQ:BRNS)

ChartMillยท26d ago

Thursday's after hours session: top gainers and losers

After the closing bell on Thursday, let's take a glimpse of the US markets and explore the top gainers and losers in today's after-hours session.

ChartMillยท26d ago

What's going on in today's session

Let's have a look at what is happening on the US markets one hour before the close of the markets on Thursday. Below you can find the top gainers and losers in today's session.

ChartMillยท26d ago

Curious about the most active stocks on Thursday?

Get a pulse on the US markets on Thursday by checking out the most active stocks in today's session. Discover the stocks that are leading the way in terms of trading volume and market activity.